Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.64 USD | -0.82% | +1.39% | -15.74% |
Financials (USD)
Sales 2024 * | 104M | Sales 2025 * | 119M | Capitalization | 192M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | 11M | EV / Sales 2024 * | 1.85 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.62 x |
P/E ratio 2024 * |
-367
x | P/E ratio 2025 * |
17.9
x | Employees | 157 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.06% |
Latest transcript on Alimera Sciences, Inc.
1 day | +5.16% | ||
1 week | +3.67% | ||
Current month | -5.90% | ||
1 month | -5.90% | ||
3 months | -6.85% | ||
6 months | +16.14% | ||
Current year | -15.05% |
Managers | Title | Age | Since |
---|---|---|---|
David Holland
FOU | Founder | 60 | 03-06-03 |
Charles Myers
FOU | Founder | 70 | 03-06-03 |
Richard Eiswirth
CEO | Chief Executive Officer | 55 | 05-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Pizzo
BRD | Director/Board Member | 57 | 10-03-31 |
Richard Eiswirth
CEO | Chief Executive Officer | 55 | 05-09-30 |
Charles Myers
FOU | Founder | 70 | 03-06-03 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 3.64 | -0.82% | 6 905 |
24-04-29 | 3.67 | +5.16% | 51,634 |
24-04-26 | 3.49 | +5.44% | 17,332 |
24-04-25 | 3.31 | -8.82% | 25,225 |
24-04-24 | 3.63 | +1.11% | 7,722 |
Delayed Quote Nasdaq, April 29, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.05% | 192M | |
-3.45% | 87.17B | |
+1.97% | 40.1B | |
+57.98% | 25.12B | |
-14.82% | 15.59B | |
-8.82% | 12B | |
-16.29% | 11.8B | |
-41.58% | 11.8B | |
+6.89% | 8.81B | |
-10.53% | 8.24B |
- Stock Market
- Equities
- ALIM Stock